Antigenic studies of animal rotaviruses : relationships by virus neutralization in vitro and cross-protection in gnotobiotic piglets by Gaul, Susan Brown
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1-1-1983
Antigenic studies of animal rotaviruses :
relationships by virus neutralization in vitro and
cross-protection in gnotobiotic piglets
Susan Brown Gaul
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Gaul, Susan Brown, "Antigenic studies of animal rotaviruses : relationships by virus neutralization in vitro and cross-protection in
gnotobiotic piglets" (1983). Retrospective Theses and Dissertations. 18306.
https://lib.dr.iastate.edu/rtd/18306
Antigenic studies of animal rotaviruses: 
Relationships by virus neutralization in vitro 
and cross-protection in gnotobiotic piglets 
by 
Susan Brown Gaul 
A Thesis Submitted to the 
Graduate Faculty in Partial Fulfillment of the 
Requirements for the Degree of 
MASTER OF SCIENCE 
Department: Veterinary Microbiology 
and Preventive Medicine 
Major: Veterinary Microbiology 
Signatures have been redacted for privacy 
Iowa State University 
Ames, Iowa 
1983 
1433363 
ii 
TABLE OF CONTENTS 
Page 
ABSTR.l\CT v 
INTRODUCTION 1 
LITERATURE REVIEW 4 · 
Historical 4 
Classification, Structure and Chemical Properties 8 
Clinical Symptoms and Pathology 12 
In vitro Culture 14 
Anti geni city 16 
Cross-protection 17 
METHODS 20 
Animals 20 
Ce 11 Cul tu re 21 
Rotavirus Strains and Isolates 23 
Preparation of Intestinal Contents or 25 
Fecal Specimens 
Indirect Immunofluorescent Antibody Test (IFAT) 25 
for Detection of Rota virus Anti gen 
Rotavirus Isolation and Culture 26 
Cell culture infectivity assay of fecal 26 
or intestinal rotavirus 
• 
iii 
Cell culture adaptation of fecal 
or intestinal rota virus 
Page 
27 
In vitro culture and assay of cell 28 
culture adapted rotavirus 
Virus cloning 28 
Virus Purification and Vaccine Preparation 29 
Serology 31 
Convalescent antiserum 31 
Hyperimmune antiserum 32 
Detection of rotavirus antibody in serum 32 
Serum neutralization test (SN) 33 
Virulence of Rotaviruses in Gnotobiotic Piglets 33 
Cross-protection Studies in Gnotobioti c Piglets 34 
RESULTS 37 
Convalescent Antisera 37 
Hyperimmune Guinea Pig Antisera 37 
Virulence of Rota vi ruses in Gnotobioti c Piglets 42 
Cross-Protection 44 
DISCUSS ION 4 9 
CONCLUSIONS 57 
BIBLIOGRAPHY 59 
ACKNOWLEDGMENTS 74 
iv 
APPENDIX 
Solutions and Reagents 
Eagles' Minimum Essential Medium (MEM) 
X-ATV (for cell culture p~ssing) 
2 X Oxoid Agar (1.2%) 
Phosphate Buffered Saline (PBS) 
Phosphate Buffered Forma 1 in 
Crystal Violet Sta.in (1%) 
Concentrated Mineral Supplement for 
Gnotobiotic Calves and Piglets 
Page 
75 
75 
75 
75 
76 
76 
76 
77 
77 
v 
ABSTRACT 
The serotype and cross-protection properties of rotaviruses 
isolated from canine, simian, bovine, porcine and human species were 
compared. The bovine strain B:USA:78:1A and canine strain C:USA:81:2 , ... ; 
were adapted to cell culture and cloned in this study. The simian strain 
S:USA:79:2, porcine OSU (Ohio State University) strain P:USA:77:1 and 
the human WA strain had been adapted to cell.culture previously by 
others but were further cloned for this work. To classify the viruses 
into different serotype groups, the serum neutralization test was used. 
Viruses exhibiting a greater than 20-fold difference in neutralization 
titer were placed into different serotype groups. Four major serotypes 
were found and were ·represented by the bovine' human' porcine, and 
canine-simian strains. These serotype differences were found to be 
significant in the cross-protection study. With the exception of the 
porcine virus, none of the strains protected against a challenge with 
virulent porcine rotavirus. Also, the canine virus did protect piglets 
against a challenge with simian virus. From these findings, it was 
concluded that only viruses belonging to the same serotype group can 
confer cross-protection and therefore vaccines should be made using the 
serotypes to which an animal is likely to be exposed. 
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INTRODUCTION 
Studies using electron microscopy and specific pathogen-free 
animals in recent years have demonstrated the presence of several enteric 
viruses in association with diarrheal disease, including: rotaviruses, 
coronaviruses, parvoviruses, astroviruses, the Norwalk and related 
agents, calicivirus-like agents, adenoviruses (enteric types), and the 
newly reported "Breda" virus. Rota virus is the virus most frequently 
associated wi'th neonatal diarrhea of humans and some species of 
animals, including calves, horses, and lambs and is conmion in the pig. 
Despite their importance as a disease causing agent, the discovery 
and characterization of rotaviruses is comparatively recent, largely 
as a result of difficulties associated with tissue culture isolation 
using conventional methods. 
Several methods have been developed for diagnosing rotavirus 
infections in animals, including electron microscopy, cell culture 
isolation and various antigenic tests. Electrophoresis of rotaviral 
RNA has proved to be a sensitive "finger-print" method for identi-
fying a rotavirus from the presence of an eleven segmented genome and 
also for subtyping rotaviruses. Despite the presence of certain 
antigens common to all isolates of rotavirus, the widespread distri-
bution of these viruses in human and all animal species studied 
including poultry, suggested the probability· that antigenic subtypes 
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exist. As a result of much investigative work by several laboratories, 
recognition of strain differences has been achieved. Antigenic 
characterization procee.ded at a rapid pace following the development 
of techniques to adapt many strains to replicate in cell culture. It 
has been shown that rotaviruses possess a common group antigen 
demonstratable by immunofluorescence, complement fixation or enzyme-
1 inked immunosorbant assay (ELISA), and that serotype-specific antigens 
are dembnstratable by serum neutralization, complement fixation and 
ELISA. Different studies on cross-protection among the rotaviruses 
have produced conflicting results. Some reports find cross-protection 
occurs between rotaviruses of different animal species whereas other 
reports fail to demonstrate cross-protection. However, antigenic 
differences by neutralization in vitro would suggest that sero-
typically different rotaviruses would not show optimal cross-protection 
in vivo. If such optimal cross-protection does not occur. between 
members of different serotype groups, any po ten ti ally successful 
vaccines should be made against all the serotypes of rotavi.rus to 
which an animal is likely to be exposed. 
This study is concerned with the antigenic characterization of 
several different animal rotaviruses (simian, canine, bovine and 
porcine). The purpose was to determine to what degree cross-
neutralization in vitro correlates with cross-protection.!!!_ vivo. 
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Isolates from different species were selected because these have been 
shown to possess major antigentc differences. From this work, 
evidence was found to support the view that rotaviruses possessing a 
20-fold or greater difference between homologous and heterologous 
serum neutralization titers do not cross-protect in vivo. However, 
' ---
where there are minor differences (8-12 fold) cross-protection may 
occur. 
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LITERATURE REVIEW 
Historical 
Current work in rotavirus research did not begin until the late 
1960s with the work of Dr. C. Mebus and his colleagues on a diarrheal 
disease of calves. A rotavirus was associated with this disease and 
was named the neonatal calf diarrhea virus (NCDV). 84 Interest in 
the rotaviruses greatly increased as workers in the medical field 
began describing s imi 1 ar viruses associated with human diarrheal 
disease and it thus seemed likely that many previously unexplained 
outbreaks of diarrhea may have had a viral origin. Although NCDV 
was not the first rotavirus discovered, it became recognized 
(although not officially) as the type species for the genus. NCDV 
has been well-characterized and it is with this virus that most new 
isolates were compared. The official type species for the genus is now 
listed as human rotavirus. As it is now known that different human 
rotaviruses ex,ist, the type species will have to be further defined. 
In retrospect, earlier studies such as those of Light and Hodes67 which 
involved the oral inoculation of calves with human diarrheic material 
with the subsequent development of diarrhea, and those of Cheever and 
Mueller23 on epidemic diarrheal disease of suckling mice (EDIM), 
have been shown to have involved rotaviruses. 105 Therefore, 
several historic studies, besides those involving NCDV, deserve 
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mention. These studies were concerned with the EDIM virus, the 
SA.11 virus (a simian strain) and the "0" or offal agent (of unknown 
origin). 
Research on infantile diarrhea in mice was first reported by 
Cheever and "Mueller in 1947. 23 In their paper, they described epizootic 
diarrhea of infant mice or EDIM. Lizbeth Kraft later, through 
transmission experiments, demonstrated a viral cause for the disease. 61 
A number of early studies were done on the EDIM virus including 
descriptions of the disease22 •23 •90 and cellular pathology. 91 •92 
The disease was not necessarily fatal. It affected primarily young 
mice between 11 and 15 days of age4 and was associated with a severe, 
yellowish, watery diarrhea. The incubation period was reported as 
varying from 40 hours to 10 days and the virus was highly infectious. 
The EDIM virus was found to be both heat- and ether-resistant and had 
an approximate diameter of 65-75 nm. 1 •61 •62 Replication of the virus 
was entirely cytoplasmic. 2 A study done by Banfield et al. 6 pointed 
out the EDIM viruses' similarity to reovirus and further" character-
ization of this virus found that it contained RNA. 88 Early attempts 
to propagate the virus in eel 1 culture were unsuccessful. 101 
Two of the first rotaviruses to be successfully propagated in 
cell culture, although they were not recognized as rotaviruses when 
isolated, were the simian agentSA.11 virus and "0" agent. The 
SA.11 virus was isolated from a rectal swab of a clinically normal 
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vervet monkey in 1958. 69 The "O" agent was isolated from intestinal 
washings from a slaughterhouse in South Africa. 69 Both of these 
viruses were cytopathic in primary vervet monkey kidney cells and were 
later shown to be morphologically indistinguishable by Els and Lecatsas 
in 1972. 32 They showed that these viruses possessed an inner capsid 
layer which resembled bluetongue virus and an outer defined capsid layer. 
Neither the "O" agent nor the SA.11 virus were associated with diseased 
animals. The history of the SA.11 virus is not fully known and the 
species of origin of the "0" agent also is uncertain. Later work has 
established that the SA.11 and "O" viruses are indeed rotaviruses. 63 •105 
As was stated previously, the work of Mebus and others in 1969 
on a calf diarrhea virus (NCDV) marks the beginning of current work on 
the rotaviruses. For the first time, gnotobiotic animals were 11sed in 
the study of neonatal diarrhea. Mebus successfully transmitted 
infection into gnotobiotic calves by ·oral inoculation of bacteria-
free filtrates of diarrheic feces. The use of gnotobiotic animals 
in diarrhea research was an important breakthrough as the ubiquitous 
nature of the rotaviruses and other enteric pathogens is now known. 
Thus, the study of these viruses in animals would be very difficult 
without the use of gnotobiotic animals. 
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The Mebus virus was first described as 'reovirus-like'. It 
measured 65 nm in diameter and after many attempts was adapted to 
. 37 83 130 grow in cell cultures of bovine embryo kidney cells. ' ' 
It was also found that infected cells in feces could be immuno-
fluoresced to identify virus positive cases in field outbreaks. This 
work on NCDV in the United States ·was confirmed by studies done in 
England in which a reovirus-like agent was isolated from diarrheic 
calves and two strains were adapted to cell culture. 16•133 
The work on calf diarrhea virus done by Mebus received little 
attention until about 1973 when Bishop and co-workers found viral 
particles, which they suggested may be orbiviruses, in intestinal 
epithelial cells of biopsy material taken from chi.ldren suffering 
from acute non-bacterial gastroenteritis. 9 Also in 1973, Flewett 
et al. found large numbers of virus particles in the diarrheic feces 
of young children by electron microscopy. 38 These viruses had a 
double layered capsid with a defined outer rim. Both reports of 
Bishop and Flewett were confirmed by others. Middelton et·a1.86 
found that most adults had antibody to a virus similar to those 
described above. This he did by an indirect fluorescent antibody 
test using a virus positive biopsy material. He was also able to 
infect a sero-negative adult with a virus positive fecal filtrate. 
Soon after the reports of.these viruses, in association with 
human diarrhea, studies were published showing similarities between 
/ 
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the bovine (NCDV) and human viruses. 40 •58 Flewett et al. reported 
cross-reactions between the bovine and human viruses by immuno-
electron microscopy and immunofluorescence and suggested that a common 
antigen exists. 40 They also noted differences from reoviruses and 
suggested that these viruses be grouped together under the name of 
rotavirus. 
Since this initial work, numerous studies have been published 
naming rotaviruses as among the major known agents associated with 
infantile gastroenteritis in many areas of the world. 29 •57 •59 
Rotavirus research has increased at a rapid pace so that today much is 
known about their structure, chemical properties, antigenic composition 
and in vitro culture requirements. However, much work remains to be 
done in the area of antigenic characterization, especially with regard 
to ~vivo work on cross-protection and virulence. 
Classification, Structure and Chemical Properties 
Several names including reovirus-like, 57 •60 infantile gastro-
enteritis virus, 94 duovirus, 29 and rotavirus40 •41 have been proposed 
for this group of enteric viruses. Of the suggested names, rotavirus 
has been accepted by the International Committee on the Nomenclature of 
Viruses73 and Rotaviruses are·now classified as a separate genus within 
the family Reoviridae. 29 •73 With the inclusion of the rotaviruses as 
a new genus, there are now three genera of animal viruses within 
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the reoviridae; the reoviruses (reovirus types 1, 2 and 3), the 
orbiviruses (bluetongue), and the rota viruses (NCDV). Viruses 
classified within the reoviridae have a segmented, double-stranded 
RNA genome, are nonenveloped and have cubic symmetry. The rota-
viruses have been shown to be antigenically distinct from the other 
two genera16 •55 •130 •132 and yet share a common antigen among them-
selves thus making them an interrelated group. 
Morphologically, the rotaviruses resemble the other members of 
the reoviridae but the bilayer appearance of complete particles 
makes them very distinct. The complete rotavirus particle has been 
described as double-shelled45 or smooth. 135 The center of the virion 
measures approximately 38 nm and its geometry is hexagonal having a 
5-3-2 symmetry which is characteristic of an icosahedron. 89 
Surrounding this electron dense inner core 1s a translucent layer 
which gives the virus a wtieel-1 i ke appearance, having a large central 
hub, short spokes and an outer rim. It is because of its appearance 
that the name, rota (which is the Latin word for wheel), was 
suggested. 40 When the outer layer is removed, the particles resemble 
orbiviruses. The incomplete, single-shelled, or rough particles 
measure 55-65 nm in diameter and are about 10 nm smaller than the 
complete particles which measure 65-75 nm. 32 •45 ,7o,3o,39,1 35 Both 
complete and incomplete particles can usually be seen in electron 
micrographs of infected fecal or cell culture material. These 
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two types of particles can be separated by cesium chlor1de centrif-
ugation.17 The buoyant density of single-shelled part1cles is 
1.38 g/cm3 and 1.36 g/cm3 for double~shelled particles. 56 The 
outer coat can be removed by chemical treatment w1th trypsin but not 
by treatment with chymotrypsin. 70 •89 , Bridger12 found that type-
specific ant1gens are associated with the outer shell whereas group 
antigens are associated with the 1nner core. .The presence of a 
hemagglutinin has been reported for some rotaviruses but has not been 
found to be a char~cteristic of the genus as a whole. 36 •49 •112 
The rotavi ruses have been found to be. very stable and resistant 
viruses. However; extensive purification may lead to instability. 
A human rotavirus stored for nine years at -20° C and another 
rota virus lyophil i zed for 30 years could be recognized as rota-
vi ruses by their morphology. 3•44 Palmer et al. have published a 
report on the stability of these viruses. 89 Their study found that 
the morphological appearance of human rotavirus remained unchanged 
after the following treatments: heat (56° C for l hour), cen-
trifugal force (100,000 x g), high salt concentration, pH 3 and 10, 
treatment with enzymes (chymotrypsin, papain, and pepsin), and 
nonionic detergents. They also found that rotaviruses were extremely 
labile to trypsin-versene and after exposure to a 0.125% concentration 
of trypsin-versene for 2 hours at 37° C they were unrecognizable. 
Ultraviolet light has been found to inactivate rotavirus. 133 
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Rotaviruses have, a segmented genome consisting of eleven 
segments of double-stranded RNA which can be separated by gel 
electrophoresis. 51 •52·•99 •120 • 121 The segments have been reported to 
range in molecular weight from 0.2 x 106 to 2.2 x 106• 53 Different 
migration patterns of the RNA segments of rotavirus from different 
species and within the same species have been observed and these 
characteristic patterns have been shown to be a fingerprint useful 
for identifying different isolates.51,53,97,98,106,120,121,122,129 
An RNA dependent RNA polymerase has been isolated from human, 
calf and simian rotaviruses. 25 •48 •71 •113 It was found in rough or 
incomplete particles but smooth particles had to be treated with a 
chelating agent to uncover the enzyme. 25 •26 
Rotaviruses have been reported to contain eleven polypeptides.71,75 
Recently, much interest has been placed on determining the functions 
of the various polypeptides and determining which RNA segment codes 
for a particular polypeptide.71•75 •76 •108 Conflicting data have been 
reported in this area. Much of the gene coding work has been done 
with the SA.11 rotavirus. 31 •108 The coding assignments· of RNA 
segments 1~6 have been determined for the SA.11 virus and these 
assignments agree with coding assignments of RNA segments 1-6 of the 
UK strain of bovine rotavirus. 76 · Conflicting data have been published 
on the remaining segments. RNA segments 7, 8 and 9 have been 
particularly difficult to assign to proteins because of their close 
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and sometimes indistinguishable electrophoretic migration patterns. 108 
It also appears that in the human virus segments 10 and 11 can be 
reversed in the migration patterns of RNA from different strains. 
Thus, segment 10 would code for the protein coded for by segment 11 
in another strain. 31 
Clinical Symptoms and Pathology 
Rotaviruses can cause an acute infection of the small intestine 
and the disease is most evident in infant or young animals and 
humans. 84 •132 Asymptomatic infections do occur. 69 Clinically, 
a short incubation period is followed by anorexia, occasional vomiting 
and diarrhea. In piglets, the incubation period but not the severity 
of infection is dependent upon the dose of virus given. 134 Mortality 
is highly variable and in economic terms, one of the most important 
aspects of the disease is the body weight loss followed often by an 
extended period of failure to gain weight. The conditions which 
determine the severity of the disease depend upon the virulence of 
the virus, the susceptibility of the animal, environmental conditions, 
and supportive therapy. Dehydration therapy has proven to be a 
successful treatment of the disease. 20 In humans, rotaviruseshave 
been associated with up to 50% of the hospitalized cases of infants 
and small children in temperate climates57 and the disease is more 
prevalent during the colder months. 
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The pathology of the disease in gnotobiotic piglets has been fully 
described by Crouch and Woode28 and by McAdaragh et a1. 74 Other 
descriptions of pathology have also been reported. 21 •65 •ll7, 134 
Briefly, McAdaragh74 reported the pathology of the disease in 
piglets as follows. The cytoplasm of villous absorptive cells in the 
duodenum and upper jejunum immunofluoresced at 12 hours and rotavirus-
specific fluorescence was most intense at 24-46 hours in the upper 
jejunum and middle small intestine. Virus replication resulted in 
the loss of the villous absorptive cells in the lower jejunum and 
upper ileum at 24 hours. Crypt hyperplasia was evi'dent and by 
scanning electron microscopy, vfll ous fusion, vi 11 ous atrophy and 
exposure of the lamina propria occurred. 
Another study, that of Crouch and Woode, 28 provided an even 
more complete picture of the disease. They reported the results of 
a serial study of rotavirus infection in gnotobiotic piglets. 
Seven-day-old piglets were infected with a pig rotavirus and the 
infection was followed for 21 days. The piglets developed the symptoms 
of anorexia, depression and diarrhea. Weight losses of about 15% 
were reported over .24-36 hours. By immunofl uorescent staining, 
infected villous epithelial cells were detected in the middle and 
distal portions of the small intestine. The number of fluorescent 
cells greatly decreased by 48 hours. Virus titrations were done on 
contents taken from the gut at various positions and times post-
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infection. Titers of the virus increased until 22 hours and then 
remained at a constant reduced level for 48 hours before gradually 
decreasing until virus disappeared at about 5 days. Intestinal 
lesions were found mainly in the middle and distal portions of the 
small intestine. Damage first appeared by 36 hours and was at a 
maximum by 46-65 hours. Lesions noted were; reduced number of 
villi, stunted villi, and some villous fusion. By five days post 
infection, the villi appeared normal although the villous length: 
crypt length ratios were smaller than in control piglets. In summary, 
Crouch and Woode concluded that recovery from infection appeared to 
consist of two phases. The first phase occurred 22 hours after 
infection. It was suggested that this first phase was apparently non-
immune in nature and was due to the loss of viral receptor sites by the 
destruction of susceptible epithelial cells and possibly to the produc-
tion of interferon or .other non-specific inhibitors. The second phase 
occurred at about 90 hours. This phase eliminated the virus and was 
thought to be due to an antibody response • 
.!!!_ vitro Culture 
Rotaviruses have been difficult to multiply to high titer in 
cell culture. The first viruses successfully adapted were the SA.11 
virus and "O" agent, 69 but as these viruses were not associated with 
disease the study did not receive much attention. The next rotaviruses 
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successfully isolated were three bovine isolates including 
Ncov16 •66 •77 •78 but most early attempts at culture failed. However, 
even though most infections were abortive after 2-3 passages, the 
cul tu res could be used for diagnostic purposes by inmunofl uorescence. 16 
A major advance occurred when .it was discovered that with the 
addition of proteol.Ytic enzymes (trypsin or pancreatin) to the culture 
media, porcine and bovine isolates adapted to culture much more 
readily5• 116 and high titer virus could be produced. 24 •35 Kidney cell 
lines are currently used for culturing purposes. Two monkey kidney 
cell lines are the most commonly used. These are lines from African 
green monkey kidneys (BSC-1) and from fetal rhes4s kidneys (MA-104). 
It is possible that structural similarities to the gut epithelium make 
these cells, probably derived from kidney tubule cells; particularly 
susceptible (i.e., the presence of microvilli, similar membrane 
bound enzymes, and presumably viral receptors). Human rotaviruses 
have been much more difficult to grow in culture. Wyatt et a1. 139 
successfully adapted a human virus (strain WA) to grow in African green 
monkey kidney cells but this occurred only after first passing the 
virus eleven times through gnotobiotic pigs. Recently, two research 
groups have reported the successful .:!..!!. vitro culture of human rota-
virus.104• 128 Briefly,. the procedure used by Urasawa et a1. 128 is as 
follows. Human fecal virus was pre-incubated with trypsin, adsorbed 
onto roller or stationary cultures of MA-104, passaged by 
16 
freeze-thawing and each passage pelleted by ultracentrifugation 
(100,000 x g) before inoculated onto fresh cultures. The adaptation 
of the rotaviruses to cell culture has enabled the production of 
high titer virus for vaccine development and further studies. 
Antigenicity 
Rotaviruses have been isolated from many species and are assumed 
to be ubiquitous. Species from which rotaviruses have been isolated 
include: calves, 84 •133 cats, 47 •109 deer, 124 dogs, 33 •42 foals, 27 •39 • 
54 ,127 humans' TO ,38,58, 115 1 ambs ,78, 111 mice' 61 monkeys' 69, 114 
pigs,65 •82 •96 •134 pronghorn antelope, 95 rabbits,1g• 93 turkeys and 
chickens. 8•5o,79,8o Rotaviruses share a common antigen which can be 
demonstrated by immunodi ffus ion, i mmunofl uorescence, comp 1 ement 
fixation, immune-electron microscopy, gel di ff us ion, and enzyme-
1 inked immunosorbant assay. 41 The rotaviruses do not.share common 
antigens with the orbiviruses or reoviruses. 16 •55 The antigenic 
relationships between bovine and human viruses was first demonstrated 
by immune-electron microscopy and immunofluorescence. 4° Common antigens 
have been reported to exist in rotaviruses from humans, calves, pigs, 
1 ambs, rabbi ts, foa 1 s, mice, the SA. 11 virus and "O" agent55 • 119 • 135 
as well as from dogs. 42 In addition to common group antigens, there 
are species-specific antigens which are demonstrated, by the serum 
neutralization test, complement fixation and ELISA.7,105,119,135, 
141 144 40 . ' Flewett et al. in 1974 found that even though human sera 
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contained antibody to the common group antigen, not all of this sera 
would neutralize bovine rotavirus. This work has been confirmed by 
other studies. 34 •105 •119 •134 •135 Thouless119 and co-workers demon-
strated differences by serum neutralization among rotavirus isolates 
from human, calf, piglet, foal, lamb, mouse, and rabbit species. Other 
studies point to differences by agglutination using immune-electron 
microscopy. 16 •105 Estes and Graham34 demonstrated differences 
between simian, porcine and bovine rotaviruses by plaque reduction. 
Thus, it is now well-established that there are group and species-
specific antigens in the rotaviruses. The species-specific antigens 
allow the categorization of rotaviruses according to serotype. 
Recently, there have been several reports of a virus morpho-
logically similar to rotavirus in pigs11 •13 •15 •103 and one in 
chickens,81 which lack the common group antigen. These viruses have 
been referred to as pararotavirus. 11 The significance and 
classification of these viruses is only begfnning to be studied. 
Cross-protection 
Once it had been established that there are different antigens 
present on rotaviruses (i.e., group and. species-specific antigens) 
the question arose as to whether infection with one rotavirus would 
protect an animal against infection with another rotavirus regardless 
of the viruses' serotype. Before such studies could begin, it had to 
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be determined whether .rota viruses would infect different species other 
than those from which they were isolated. Several studies have 
determined that cross-species infections can occur. The earliest 
studies that indicated that cross-infections may occur were those of 
Light and Hodes in 1943 and 1949.67 •68 They infected calves with a 
filtrate of human diarrheic feces. These feces were later shown to 
con ta in rota virus although whether the virus i nocul at ion was actually 
a human strain is not certain. Flewett and others in 1974 reported 
an unsuccessful attempt to infect calves with a human virus. 40 
However, later studies did report the successful infection of calves 
with hi.Iman rotavirus. 85 The human virus has since been reported to 
experimentally infect piglets without clinical signs18•136 and with 
clinical signs, 55 •123 •126 •142 to infect monkeys and cause diarrhea, 140 
and to infect dogs asymptomatically. 125 Pi gs have been successfully 
infected with calf rotavirus, 132•136 lamb rotavirus, 136 and foal 
rotavirus. 127 •136 Also, the presence of neutralizing antibody to 
pig rotavirus in cow colostrum could be indirect evidence for the 
infection of cattle with porcine rotavirus. 14 Thus, it has been 
experimentally determined that cross-species infections can occur. 
It was hoped that heterologous protection in the rotaviruses 
would be successful. This would allow the use of less virulent 
viruses from other species to be used as vaccines thereby saving 
on the cost of attenuation of a virulent homologous strain. 
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Studies ·on cross-protection have produced conflicting results. It 
appears that poor or only partial cross-protection will occur across 
serotypes. 131 Studies with the human virus indicate that sequential 
infections can occur between types I and ri. 100 Bovine rotavirus as a 
vaccine did not protect piglets against challenge with porcine 
rotavirus. 64 In a study done by Woode and others, only approximately 
a 30% cross-protection rate was achieved when using foal or human 
virus as vaccine and bovine rotavirus as challenge. 131 Tzipori et al.126 
reported that piglets vaccinated with human.rotavirus were protected 
against clinical disease but not against virus shedding when challenged 
with porcine rotavirus. Wyatt et al. 138 described a similar situation 
when calves vaccinated.in utero with bovine rotavirus were protected 
against clinical disease but did shed virus when challenged with human 
rota virus. Al though heterologous cross-protection studies continue; 
this work and the work of others indicate that this is a less than 
perfect approach to vaccination. 
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METHODS 
Animals 
The National Animal Disease Center, Ames, Iowa supplied the 
guinea pigs used for the production of hyperimmune antfsera. 
Gnotobiotic anima·ls are necessary in rotavirus research due to 
the ubiquitous 'nature of the viruses. Most of the materials used for 
the isolators were purchased from Standard Safety Equipment· Company, 
Palatine, IL and from Allied Fabricating, Columbus, OH. The isolators 
were assembled and maintained by I. Zook. In preparation to receive 
the animals, isolators were washed with a 10% Wescodyne Solution 
(American Sterilizer Company, Erie, PA) and sterilized by fogging with 
a 2% peracetic acid solution (peracetic acid, water, and a few drops 
of liquid detergent). Portions of the cages were sterilized by 
autoclaving. Those materials which were heat-labile were gas-
sterilized with ethylene oxide. Once in operation, any materials 
entering the isolators were handled with gloves and sprayed with 
the peracetic acid solution. The entry port was also sprayed and the 
material remained fn the port for a minimum of thirty minutes before 
passing through to the inside. 
Gnotobiotic rats were purchased from Charles Rivers Laboratories, 
Willmington, MA. When received, they were aseptically transferred 
into a prepared sterile isolator. Sterile feed and litter were 
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purchased from Charles Rivers and water for the rats was autoclaved. 
Gnotobiotic pigs were derived according to the method of Miniats 
and Jo1 87 and gnotobiotic calves were derived following the procedure 
of Matthews et a1. 72 The sows or cows were placed under general 
anesthesia and the young removed by ~aesarean section. Dr. L. Evans 
was responsible for the surgical procedures. The calves and piglets 
were immediately passed through a germicidal trap filled with a 10% 
Wescodyne solution into sterile gnotobiotic isolators where they were 
resuscitated. Gnotobiotic piglets were fed canned evaporated milk 
(Carnation, Los Angeles, CA) or SPF-Lac (Borden Labs, Elgin, IL), The 
calves were fed evaporated milk diluted 1 :1 with a mineral water sup-
plement. The ca·l ves were fed the evaporated mi 1 k prepared as for the 
pigs. 
Cell Culture 
Three cell lines were used in this study; MDBK, BSC-1, and 
MA-104. MA-104 cells were originally developed by M. A. Bioproducts, 
Walkersville, MD and were kindly supplied by Dr. M. Cholmley. This is 
an established cell line of fetal rhesus monkey kidney cells. BSC-1 
cells46 are a~ established line of African green monkey kidney cells 
and were supplied by Dr. L. A. Babiuk. The MDBK cells (Madin Darby 
Bovine Kidney) are an established line of bovine kidney cells and 
were kindly provided by Dr. K. Theil. 
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Both MA-104 and BSC-1 cell lines were used for virus culture. 
Cultures of MA-104 or BSC-1 cells were prepared in 96-well microtiter 
plates (Costar, Cambridge, MA), in 75 or 25 cm2 flasks (Linbro, Hamden, 
CT), and for large scale antigen production, in 850 cm2 roller 
bottles (Corning Glass Works, Corning, NY). The growth medium 
consisted of Eagles Minimum Essential Medium (MEM) supplemented with 
0.25% lactalbumin hydrolysate (Difeo Laboratories, Detroit, MI), 
penicillin (100 IU/ml), streptomycin (100 µg/ml), amphotericin B 
(5 µg/ml), fungizone (E. R. Squibb and Sons Inc., Princeton, NJ) and 
10% fetal bovi.ne serum (GIBCO Laboratories, Grand Island, NJ). At two 
days of age, the exhausted medium was removed from the culture flasks 
and was replaced with MEM containing 5% fetal bovine serum. After 
the medium change, the cells could be maintained for up to three 
weeks by removing the exhausted medium and replacing it with serum-
free MEM (SFM) at two.day· intervals. MA-104 or BSC-1 cells were passed 
into flasks, microtiter plates or culture tubes when they were 3-7 
days of age. The cells from one 75 cm2 flask were trypsinized and 
resuspended in 60 ml of MEM containing 10% fetal bovine serum. 
Approximately 100 µl of this suspension were added to each well of 
the microtiter plates, 2 ml were added to each culture tube, and 20 ml 
were added to each 75 cm2 flask. 
MDBK cells were grown in the same medium as described above. 
These cells were passed every 3 days by adding 60 ml of MEM 
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containing 10% fetal bovine serum to the trypsinized cell monolayers 
of one 75 cm2 flask and dispensing 20 ml of the cell suspension into 
each 75 cm2 flask. For plaquing, confluent cell cultures were passed 
undiluted following trypsinization and l ml of the cell suspension 
was added per well of an 8 well culture plate (Lux brand, Flow 
Laboratories Inc., McLean, VA). 
Rotavirus Strains and Isolates 
The rotavirus strains used in this study are designated using 
the terminology suggested by Dr. Woode of the FAO/WHO Comparative 
Virology Program (rotavirus subgroup) and first published in a report 
by Stuker et al. 114 The nomenclature lists in order, separated by 
colons: the first letter of the species from which the virus was 
isolated, the country in which the isolation took place, the year the 
isolate was discovered, and finally the number of the isolate. The 
porcine rotavirus (OSU strain, P:USA:77:1) was kindly supplied by 
Dr. E. Bohl at passage 32 in MA-104 cells116 and the OSU vaccine 
strain was supplied by Ambico Inc., Dallas Center, IA. The OSU strain 
of porcine rotavirus was originally isolated from a 2-week-old 
conventional pig with clinical diarrhea at Ohio State University and 
subsequent passages in gnotobiotic piglets demonstrated virulence. 102 
This strain is generally accepted as the type strain of porcine 
rotavirus. Dr. N. Schmidt kindly provided the simian rotavirus 
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(S:USA:79:2) at passage 15 in cell culture and plaque purified. 114 
This sim1an rotavirus was isolated from a 3.5-month-old rhesus 
monkey with diarrhea. 49 The animal was raised at the California 
Primate Research Center, University of California, Davis, and thus 
was exposed to human contact. The possibility thus exists that this 
virus could possibly be a human strain wh1ch infects monkeys. The 
virus is antigenically closely related to SA.11 49 but its history 
is better documented. Dr. R. Wyatt supplied the WA strain of human 
rotavirus (serotype 2) at passage 16 in cell culture and plaque 
purified. 139 This strain was originally isolated from a pediatric 
patient (WA) with diarrhea. 139 It was passaged eleven times in 
gnotobiotic piglets and then adapted to grow to relatively high titer 
in primary cell cultures of African green monkey kidney cells. The 
canine isolate (LSU:79C-36,C:USA:81:2) was isolated from a two-day-old 
puppy with diarrhea. 42 The bovine rotavirus (Bl4 isolate, B:USA:79:1A, 
antigenically related but distinguishable from NCDV, B:USA:72:1) 
was isolated from a diarrheic calf in Iowa. The canine and bovine 
isolates were cloned .by limiting dilutions after adaptation to cell 
culture and the canine isolate was further cloned by plaque selection. 
Rotavirus isolates B641,· B681, B720, and B756 were detected in the 
diarrheic feces· of calves from Florida, Iowa, Pennsylvania, and Iowa, 
respectively. 
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Preparation of Intestinal Contents or Fecal Specimens 
Intestinal contents or fecal specimens were diluted 1 :3 by volume 
in phosphate buffered saline (PBS) at pH 7.2, mixed well, and cen-
trifuged at 7,500 RPM (6,000 x g) for 1 hour. The supernatant was 
removed and used for cell culture iso)ation or electron microscopy. 
Indirect Immunofluorescent Antibody Test (!FAT) for 
Detection of Rotavirus Antigen 
Rotavirus infected and uninfected control cultures in microtiter 
plates or coverslips were wet-fixed with acetone before CPE developed. 
To avoid opacity developing in the plastic of the microtiter plates 
due to the acetone treatment, the acetone was diluted with phosphate 
buffered saline (PBS) to 80% and stored and used at -24° C. The 
glass coverslips were fixed with undiluted acetone. After the 
preparations were dry, they were stored at -24° C or used irrnnediately. 
They were rehydrated with PBS for two minutes and then the PBS was 
discarded. Two drops of gnotobiotic calf convalescent antiserum.at 
a 1:40 dilution in PBS were added to each well (or coverslip) and the 
plates were then incubated for one hour at room temperature. The 
plates were then washed five times with PBS and two drops of 
fluorescein conjugated rabbit anti-bovine gamma globulin were added 
per well (or coversl1p) and the cultures were again incubated for one 
hour. The preparations were then washed five times with PBS, shaken 
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free of fluid and. 1 drop of 90% glycerin in PBS was added per we 11. 
The plates were inverted and read with a vertically transmitted ultra-
violet light microscope through the lOX objective. A similar pro-
cedure was followed with the coverslip preparation. These, however, 
could be viewed through a lOX or 25X,objective and gave better reso-
lution. As some brands of microtiter plates did not transmit ultra-
violet or excited light only only the Costar brand plates were used. 
Rotavirus Isolation and Culture 
Cell culture infectiVity assay of fecal or intestinal rotaVirus 
Fecal or intestinal content supernatants were treated with an equal 
volume of 0.01% EDTA-free trypsin (1:250 Difeo Laboratories, Detroit, 
MI) giving a final concentration of 500 µg/ml. This mixture was 
incubated for 30 minutes at 37° C and then diluted 1:10 in SFM 
containing 0.1% pancreatin (GIBCO Laboratories, Grand Island, NJ). 
MA-104 cells, 4-7 days ·Of age, in 96 well microtiter plates were washed 
with SFM containing 0.1% pancreatin and 100 µl of the fecal dilution 
was added to each of 8 wells. The plates were then incubated for 24 
hours at 37° C. After the incubation period, the media was removed 
from the plates and ·the cells were fixed with cold (-24° C) 80% 
acetone for 10 minutes. The acetone was then removed and the plates 
dried completely 'and immunofluoresced or stored at -24° c until 
stained. 
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Cell culture adaptation of fecal or intestinal rotavirus 
Virus from some rotavirus positive feces (as detected by the 
cell culture infectivity assay) were adapted to cell culture. The same 
procedure was used for adaptation as was used for the cell culture 
infectivity assay described previously except that 25 cm2 flasks 
(or test tube cultures) of MA-104 cells replaced the microtiter plates. 
Confluent cultures of MA-104 cells were 4-7 days of age when used. A 
negative control flask was always passed immediately prior to the 
passage of the virus flask to check for possible cross-contamination 
from other rotaviruses. The virus present in the supernatant fluids 
(and cells and cell debris) was passed by freeze-thawing, or by the 
addition of trypsin to strip the monolayer, every 24-48. hours if 
cytopathic effect (CPE) was not 100%. Cells from the control and 
virus flasks were used to check for the presence·of rotavirus by IFAT. 
Generally, if CPE was observed during the early passages, the flasks 
were allowed to incubate until CPE was 100% (not more than 3 days). 
When viral CPE was 100% within 24-48 hours, the titer of the virus was 
generally high enough (105-1 o7 /50% tissue culture infective doses) for 
the virus to be used in various .assays and tests. Each passage of the 
virus and its ·control were aliquoted and stored at -70° C. 
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In vitro culture and assay of cell culture adapted rotavirus 
Rotavirus isolates were considered to be adapted to growth in cell 
culture by the third or fourth passage at which time their titer was 
105 to 107 50% tissue culture infective doses (TCID50), clearly demon-
strating that replication of the viry.s had occurred.!.!!_ vitro. Ceil 
culture adapted rotav.irus was propagated in 75 cm2 flasks of MA-.104 
cells with SFM containing 0.1% pancreatin and passed when CPE was 100% 
[usually within 24 hours post-infection (PI)]. For assay of the virus 
ten-fold dilutions were made in the above medium and 100 µl of each 
dilution added to each well of a microtiter plate of MA-104 cells 
(3.-5 days of age); which had been rinsed two times with SFM and . 
0.1% pancreatin. The cultures were incubated 4-5 days at 37° C. The 
endpoint was read by CPE using an inverted microscope. The cultures. 
were fixed with 10% phosphate buffered· formalin for about one hour, 
stained with 1% crystal violet for ten minutes, rinsed with water, 
dried and stored at room temperature. 
Virus cloning 
Viruses were cloned by limiting dilutions or by plaque selection. 
Cloning by limiting dilutions was done by making ten-fold dilutions of 
the virus in SFM containing 0.1% pancreatin and inoculating these 
dilutions onto flying coverslip cultures of MA-104 or BSC-1 cells. 
The highest dilution at which infected cells could be detected by 
IFAT ·was designated a clone. This clone was passed once into a flask 
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of cells, incubated for 24-48 hours and the procedure repeated for a 
total of three clonings. For cloning by plaque selection, dilutions 
of the virus were made as described above and l ml of each dilution 
was added to each well of an 8 well tissue culture plate containing 
a 2-3 day old confluent monolayer of MDBK cells. The virus was 
allowed to adsorb for l hour at 37° c. The inoculum was then 
removed and an overlay consisting of equal volumes of 2x MEM and 2x 
oxoid agar (Oxoid Ltd., London, England), and 0.1% pancreatin and 
0.003% neutral red, was added. The cultures were incubated at 37° C 
with minimal light exposure as neutral red is phototoxic. At about 
three days when plaques were visible, a well with less than about five 
plaques was selected and one plaque of infected cells,· separated from 
other plaques was removed by scraping with a bent pasteur pipet.· This 
plaque was then inoculated into a flask of MA-104 cells and grown as 
described previously. This procedure was repeated for further 
purification. 
Virus Purification and Vaccine Preparation 
Rotavirus grown in MA-104 or BSC-1 cells (usually in roller 
bottle culture) was ·harvested by freeze-thawing two times.· The 
rotaviruses generally grew to a titer of 105-107 TCro501100 µl 
in roller bottle culture. To remove the cell debris, the media and 
cells were centrifuged at 6,000 xg and the supernatant virus was 
30 
pelleted at 80-100,000 xg for 1.5 hours in a Beckman L-65 ultra-
centrifuge, resuspended in PBS and extracted with an equal volume of 
trichlorotrifluoroethane (DuPont Co., Wilmington, DE). The aqueous 
phase was pelleted through 40% sucrose at 80-100,000 xg for 4 hours. 
The virus-containing pellet was resuspended in_ a small volume of 
PBS and stored at 4° c. 
The purified virus pellet was used to vaccinate guinea pigs in 
order to produce hyperimmune sera. Non-inactivated rotavirus from 
3-6 roller bottle cultures was pelleted and diluted approximately 
1:50 in PBS for vaccination purposes. 
Fecal rotavirus used for oral vaccination (or for challenge) of 
the gnotobiotic animal:s was prepared by diluting the rotavirus con-
taining feces 1:50 in SFM, then mixing and centrifuging at low speed 
(6,000 xg). The supernatant was removed and filtered through a 
0.45 µm filter. One drop of the filtrate was sterility-checked on 
blood agar plates ·24-48 hours prior to inoculation. Cell culture 
adapted rotavirus was used for vaccination at approximately 107 
TCID50 per 100 µl, and was filtered (0.45 µm) and sterility-checked. 
The inocula (from feces or cell culture) were assayed for cell 
culture infectivity using the method described previously. 
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Serology 
Convalescent antiserum 
Convalescent antiserum was obtained from gnotobiotic pigs, calves, 
and rats which had been inoculated orally and/or nasally with rotavirus 
vaccines (prepared as described previously) and bled 2-3 weeks post-
inoculation. Most of the animals received either cell culture 
adapted rotavirus or rotavirus from fecal samples collected in the 
field. Some of the animals received a gnotobiotic pass of the cell 
culture or fecal virus as a vaccine. 
Convalescent antiserum was raised in gnotobiotic rats as follows. 
The rats (six females) were six weeks of age when received. They were 
allowed an adjustment period of one week. At the end of that time, one 
rat (Rat A) was removed from the isolator and bled out for a negative 
prevaccination control serum. The remaining five rats received an 
oral inoculation of approximately 1 ml of canine rotavirus at passage 8 
in cell culture (approximately 107 TCID50 1100 µl) and had a low 
dilution of the virus in their drinking water for 24 hours. Fecal 
samples were collected daily and the animals were bled out three 
(Rats Band C) or four (Rats D, E, and F) weeks post-infection (PI). 
Convalescent antiserum was prepared in gnotobiotic calves by the 
following method. The calves were vaccinated at .one day of age with 
an oral-nasal inoculation of 5 ml of cell culture or fecal rotavirus 
prepared as described previously. The animals were bled three weeks 
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PI. Antiserum in gnotobiotic pigs was prepared similarly except that 
the animals received l ml of vaccine. 
Hyperimmune antiserum 
Hyperimmune antisera were obtained from guinea pigs which had 
been inoculated in the footpad twice at three week intervals with 
0.1 ml of rotavirus in Freund incomplete adjuvant. The inoculum 
was prepared by emulsifying equal volumes of purified non-inactivated 
rotavirus and Freund incomplete adjuvant. Some of the guinea pigs 
received virus in Freund complete adjuvant for the first inoculation 
but this procedure was discontinued because the footpads became very 
swollen and developed open sores. The animals were bled three weeks 
after the last injection. 
Detection of rotavirus antibody·in serum 
Adaptations of a method described by Woode et al. 135 were used 
to detect rotavirus antibody in serum by immunofluorescence (IF). 
Sera were screened for the presence of rotavirus antibody (IF) at a 
1:10 dilution in PBS. The dilution was added to a rotavirus antigen 
plate which. was made as follows: microtiter plates of MA-104 cells 
were inoculated with 100 µl/well of 100-1000 TCio50;100 µl of.canine 
rotavirus (in SFM with 0.1% pancreatin), incubated for 24 hours at 
37° C, fixed with 80% cold (-24° C) acetone for 10 minutes, dried 
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and stored at -24° C. The remainder of the test was the same as 
that described for an !FAT except that the anti-gamma globulin 
fluorescein conjugate varied according to the species from which the 
serum to be screened originated. In some cases, the sera were 
titrated by 2-fold dilutions in PBS and the endpoint was recorded as 
a 50% decrease in fluorescence from one dilution to the next. 
Serum neutralizati'on test (SN) 
Cell culture adapted rotavirus was diluted to 100-1000 TCID50; 
100 µl in SFM containing 0.2% pancreatin. Serial 2-fold diluti.ons 
of serum were prepared in SFM. An equal volume of serum and virus 
dilutions was incubated at 37° C for l. 5 hours and then 100 µl of the 
preparation was added to each of 4-8 wells'of a microtiter plate 
containing monolayers of 3-5 day-old MA-104 cells. The cultures were 
incubated for five days at 37° C, then fixed with formalin and 
stained with crystal violet as described previously. 
Virulence of Rotaviruses in Gnotobiotic Piglets 
All piglets in the experiments were weighed and observed daily for 
changes in their condition. Rotaviruses orally inoculated into 
gnotobiotic piglets were judged to be virulent based upon the following 
parameters. Clinical signs of disease included, fecal soiling of the 
skin and cage area, depression, refusal to feed, vomiting, diarrhea, 
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weight loss (or failure to ga1n weight), and sometimes death. 
Diarrhea was recognized as a sudden change in fecal color from the 
normal dark brown to light yellow or white, a marked increase in the 
fluid nature of the feces, and an increased volume. Fecal samples 
from clinically normal pigs were often small and difficult to obtain. 
However, fecal samples from p1gs with diarrhea were easily obtained 
in relatively large amounts. Piglets were weighed daily using a 
spring balance to the nearest 25 g :!:. 5 g. Each litter of piglets 
used consisted of at least two piglets for controls. A comparison 
of weight curves of control vs. experimental animals, and of pre- and 
post-challenge animals was made to determine whether weight loss or 
a failure to gain weight had occurred. 
Cross-Protection Studies in Gnotobiotic Piglets 
After initial experimentation to determine the vir.ulence of 
various rotavirus isolates to the pig, the gnotobiotic pigs were used 
as the animal model for the cross-protection studies. One way cross-
protection work was done in the pigs using the bovine, canine, and 
simian viruses as vaccines and the OSU virulent strain of porcine 
rotavirus as the challenge virus. Pigs vaccinated with simian and 
canine viruses were challenged with the simian virus. For control 
of these comparative cross-protection experiments, some pigs received 
cell culture adapted and attenuated OSU rotavirus as a vaccine and 
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virulent OSU rotavirus as a challenge virus. Control pigs which 
received no vaccines but were challenged were included in every 
litter; Most of the animals received either cell culture adapted 
rotavirus or rotavirus from feces collected in the field. However, 
the OSU porcine rotavirus used as the challenge virus in the cross-
protection studies was a fecal filtrate of a gnotobiotic passage in 
piglets of virulent OSU porcine rotavirus which was prepared as 
follows. Virulent rotavirus (gnotobiotic pig fecal filtrate provided 
by Dr .. E. Bohl) was inoculated intranasally into two 26-day-old 
gnotobiotic piglets. Upon the onset of diarrhea, the intestinal 
contents were harvested, pooled, diluted to approximately lo4•1 
TCID50/ml, filtered, and stored at -70° c. 
Piglets received l ml of inoculum intranasally-orally for 
vaccination or challenge. They were usually vaccinated at birth and 
challenged at two weeks of age. Fecal samples were collected daily 
after vaccination for.one day before challenge and for several days 
after challenge. The piglets were weighed daily during the early 
portion of the experiments to determine the virulence of the 
vaccine virus but often as the pigs grew the weight recording was 
inaccurate and was not recorded during the period following challenge. 
Animals were observed daily for clinical signs of disease. The pigs 
were bled prior to the challenge and sometimes at the termination of 
the experiment. The sera were checked for anti-rotavirus antibody by 
IFAT or SN. 
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The absence or presence of fecal rotavirus post-challenge was 
• 
used to indicate cross-protection or the lack of cross-protection. 
The presence or absence of diarrhea following challenge was viewed as 
a very subjective judgment although in most susceptible pigs anorexia 
and diarrhea were readily observable. Excretion or the lack of 
virus in the feces was thought to be the best indicator of whether or 
not cross-protection had occurred. 
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RESULTS 
Convalescent Antisera 
The comparative SN titers of convalescent antisera from orally 
inoculated animals are given in Table 1. Some sera showed 16- to 128-
fold differences between homologous and heterologous titers, e.g., the 
OSU SN titer of antiserum to OSU (Hl808) and the convalescent dog serum 
to a canine rotavirus. The gnotobiotic piglet from which the OSU anti-
serum (Hl808, provided by Dr. E. Bohl) was collected was a convalescent 
animal that was also hyperimrnunized. This serum clearly differentiated 
(i.e.,> 20-fold difference) between porcine and human, bovine, and 
simian but only demonstrated a 16-fold difference between porcine and 
canine. The only strictly convalescent serum which clearly differen-
tiated among the viruses was .that from a conventionally reared dog 
convalescent to a natural infection with a canine rotavirus. This serum 
demonstrated a difference of 80-fold between canine and porcine, simian, 
and bovine rotaviruses. Other convalescent sera failed to distinguish 
between the different rotavirus isolates, e.g., gnotobiotic calf 
and pig antisera convalescent to 814 rotavirus. 
Hyperimmune Guinea Pig Antisera 
As preliminary data with the convalescent antisera did not 
definitively distinguish among all of the rotavirus isolates, 
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Table 1. Comparative SN titers of convalescent and.hyperimmune sera 
Vaccinea SN titers 
to the following viruses 
virus Animal osu Canine SIM ·B14 WA 
osu gnoto pig Hl808b 6400 400 160 100 50 
gnoto pig I II, l > 800 400 100 NDc ND 
Canine dog 38d < 10 800 ::. 10 ~ 10 ND ·-
gnoto pig II' 4 200 800 800 40 ND 
gnoto pig II, 5 200 1600 1600 100 ND 
gnoto rat B < 40 800 200 < 10 ND 
gnoto rat C < 20 800 800 < 10 ND 
gnoto rat D < 40 400 200 < 20 ND 
gnoto rat E < 40 800 100 < 10 ND 
gnoto rat F < 20 800 200 < 40 ND 
Sim gnoto pig III, 3 20 > 800 400 ND ND 
gnoto pig VIII, 5 ND 200 200 ND ND 
814 gnoto calf GC 5e 1600 800 800 1600 400 
gnoto pig I, 4 80 80 100 100 ND 
gnoto pig I, 6 40 80 80 100 ND 
aCell culture rotavirus. 
bconvalescent animal also hyperfrranunized by intramuscular fnocula-
tion of virus without adjuvant. 
cND, not done. 
dConvalescent serum from a dog naturally infected with a canine 
rotavirus. 
eConvalescent animal also hyperimmunized by one intramuscular 
inoculation of virus.mixed with Freund incomplete adjuvant. 
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hyperimmune antisera were produced and subsequently were shown to be 
able to clearly differentiate the isolates. All of the guinea pigs 
used to produce hyperimmune antisera had been exposed to rotavirus 
(unknown strain) prior to inmunization. In Table 2 are recorded the 
IF titers of the guinea pig sera to canine rotavirus antigen prior 
to hyperimmunization (which ranged from 10-160) and after hyper-
immunization. The IF antigen represents the antigen common to all 
rotaviruses. There was a significant rise in IF titer in all the 
animals except those with high initial titers. Despite this previous 
exposure, highly specific antisera were acquired from most of the 
guinea pigs used. Table 3 lists the comparative homologous and 
heterologous SN titers of.the guinea pig hyperimmune antisera. 
Differences of 20-500 fold were observed between homologous and 
heterologous SN titers. It was arbitrarily decided that a 20-fold 
difference between homologous and heterologous SN titers was the 
minimum difference used for distinguishing serotypes. However, 
lower differences are still significant. From the results in Table 3, 
the isolates of rotaviruses studied could be classified into four 
dist.inct serotype groups on the basis of differences in SN titers 
of 20-fold or greater. The four groups are represented by the porcine 
rotavirus (OSU), the bovine rotavirus (Bl4), the human ·rotavirus (WA), 
and the two isolates· of simian (S:USA:79:2) and canine (C:USA:81:2). 
Canine and simian rotavfruses showed identical or less than 20-fold 
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Table 2. IF.titers of guinea pig sera pre- and.post-hyperiTI111unization 
Pre- Post-
V . . a hyperimmunization hyperimmunization Animal no. . acc1ne virus IF titer . IF. titer 
17 Canine 160 640 
18 Canine 10 800 
19 Canine 160 NDb 
34 Simian 40 800 
35 Simi an 10 800 
36 Simian 10 800 
37 Bovin~ (814) 10 400 
38 Bovine 10 800 
39 Bovine 10 800 
40 Bovine 10 400 
41 Bovine 20 200 
42 Porcine (OSU) 10 200 
43 Porcine 20 400 
44 Porcine 10 200 
aCell culture rotavirus. 
bNot done. 
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Table 3. SN.titers .of.guinea p.ig sera hyperinmune to various rota viruses 
Vaccine · SN titers to the following vi ruses 
virusa Animal # Canine Simian 814 osu 8641 WA 
Canine 17 51;200 12 ,800 800 400 NDb ND 
Canine 18 . 102;400 12,800 400 < 100 ND ND 
Canine 19 . 102;400 6,400 200 < 100 ND ND 
Simian 33 12,800 . 12;800 400 400 ND· ND 
Simian 34 6,400 12 ,800 < 100 < 100 ND ND 
Simian 35 256,000 12 ,800 200 < 100 ND ND 
Simi an 36 .12,800 . 12;800 < 100 < 100 ND ND 
814 37 < 100 < 100 · 12 ,800 < 100 ND ND 
814 38 < 100 < 100 6;400 < 100 ND ND 
814 39 < 100 < 100 25,600 < 100 ND ND 
814 40 < 100 < 100 12 ;800 < 100 ND ND 
osu 41 < 100 < 100 < 100 6,400 ND ND 
osu .42 < 100 < 100 < 100 1 ,600 . ND ND 
osu 43 < 100 < 100 < 100' 3>200 ND ND 
osu 44 < 100 < 100 < 100 . 6,400 ND ND 
8641 45 < 100 < 100 3,200 < 100 ·l,600 100 
8641 46 < 100 < 100 3,200 < 100 3,200 < 100 
8641 47 < 100 < 100 6,400 < 100 3,200 < 100 
8641 48 < 100 < 100 3,200 < 100 1;600 < 100 
WA 49 < 100 < 100 < 100 < 100 ND 400 
WA 50 < 100 < 100 < 100 < 100 ND 3,200 
WA 51 < 100 < 100 < 100 < 100 ND 1,600 
. WA 52 < 100 < 100 < .100 < 100 ND 3,200 
aCell culture rotavirus. 
bND, not done. 
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differences with the exception of a convalescent dog serum which 
showed an BO-fold difference (Table 1). One guinea pig serum 
(serum no. 19) showed an approximate 16-fold difference between 
canine and simian. In contrast, the four serotype groups showed SN 
titer differences varying from each other by 32-fold (serum no. 43) 
to a maximum of approximately 500-fold (serum no. 19). There was 
marked variation observed in the immune responses between the 
different guinea pigs inoculated with the same antigen, particularly 
among the simian and human rotavirus inoculated. guinea pigs. It 
should be noted that some sera failed to differentiate clearly between 
the groups (sera nos. 49, 51, 52), but these sera al.so showed low 
homologous titers. As these guinea pigs were all inoculated with the 
same antigen preparation (human rotavirus, WA strain), it is probable 
that the poor responses were the result of a relatively low concentra-
tion of antigen in the vaccine. However, none of the sera were 
tested below a 1:100 dilution so 1t is possible that the heterologous 
titers could be less than 50 which would demonstrate the 20-fold 
difference required to show that the viruses belong in different 
serotype groups. 
Virulence of Rotaviruses 1n Gnotobiot1c Piglets 
The clinical signs associated with a virulent rotavirus infection 
are anorexia, diarrhea, occasional vomiti.ng, an associated weight loss, 
43 
a period of failure to gain weight and sometimes death. However, the 
mortality rate is variable. Using the above criteria but excluding 
mortality as a required property, rotaviruses were judged to be 
virulent or avirulent to the gnotobiotic pig. 
Vaccinated and control piglets which remained clinically normal 
continued to gain weight at an average rate of approximately lOOg/ 
day. These animals did not show more than one day of failure to 
gain weight. Piglets which demonstrated clinical signs of disease 
following vaccination or challenge showed a weight loss or failure to 
gain weight for three or more days. This failure to gain weight 
resulted in a 25-40% reduction of their potential weight 3-5 ·days 
post-infection, which was determined by extrapolation from their own 
weight curve before disease and in comparison to control curves. 
Based on weight gain failure and clinical signs, the virulent OSU 
rotavirus, canine rotavirus and bovine rotavirus strains 6681 and 
B756 were judged to be virulent in these experiments. 
OSU virulent fecal rotavirus when inoculated orally into 2-week-
old piglets produced· a severe diarrhea within 24 hours.. The feces 
were very watery and contained yellow flecks. There was rapid 
development of dehydration and an accompanying weight loss. The 
piglets also vomited. When the OSU virulent strain was. fed to 
two 3-day-old piglets, both died after 2-3 days of diarrhea. 
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Because the effect of the OSU rotavirus on the piglets was so 
pronounced (i.e., virulent) it was selected as the challenge strain 
in the cross-protection work. This virus was the most virulent to 
the piglets and therefore presented the most severe challenge to 
any vaccine used. 
The canine tissue culture adapted rotavirus caused detectable 
signs of disease in four out of six piglets. These signs included, 
loss of appetite and weight loss or a failure to gain weight and 
diarrhea. 
The bovine isolates 8681 and 8756 were also judged to be virulent 
on the basis of the criteria described previously, although only one 
pig out of two inoculated showed a noticeable difference in weight 
gain. 
Cross-Protection 
The results of the cross-protection studies in gnotobiotic 
piglets are recorded in Table 4. Pre-vaccination sera were negative 
for rotavirus antibody at a 1:10 dilution by IF. All rotavirus 
isolates used as vaccines infected, multiplied and caused sero-
conversion in the piglets. Of the vaccines used, only the OSU 
serotype vaccine virus protected the piglets against cha 11 enge with 
virulent OSU rotavirus as determined by a lack of clinical signs of 
Table 4. Cross~protection studies in .gnotobiotic piglets 
Before challenge. 
No. of 
Age animals 
No. of vaccinated Vac~inea with Virus b 
animals (days) virus diarrhea. excretion 
2 7 osud 0 + 
4 l osud 0 + 
4 l Bl4d 0 + 
2 7 B720g 0 + 
2 7 86419. 0 + 
2 l B64lg 0 + 
2 l B68lg 2 +. 
2 l B756g . 2 + 
4 l Canined 2 + 
4 l Simi and 0 + 
10 NAi Controls 0 
2 NA Controls 0 
2 l Canined 2 + 
2 l Simi and 0 + 
2 NA Controls 0 
aThe virus was administered at 10 7 50% tissue cu.lture infective 
doses. 
bcell culture isolation from feces detected by IF for at least 3 
days after vaccination. 
cCell culture isolation from feces detected by IF for at least 3 
days after challenge. 
dGell culture rotavirus. · 
eND, Not done. 
fosu virulent virus. 
9Fecal filtrates of bovine rotavirus. . 
hserum was IF positive at 1:10 dilution to canine rotavirus 
anitgen. 
iNA, Not applicable. 
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NT titer of prechallenge 
sera to following.virus: After challenge 
No. of 
Age animals Virus 
challenged Challenge with excre-
Vaccine osu Simian (weeks) virus· ·diarrhea t' c · ion 
> 800 > 800 NDe 3 osuf 0 
> 800 > 800 . ND 2 osuf 0 
40-160 < 10 ND 2 osuf 4 + -
NDh 10-20 ND 4 osuf 2 + 
NDh 10-20 ND 4 osuf 2 + 
NDh < 10 ND 2 osuf 2 + -
NDh < 10 ND 2 osuf 2 + -
NDh < 10 ND 2 osuf 2 + -
160-180 < 10 ND 2 osuf 4 + -
80-400 < 10 ND 2 osuf 4 + -
NA < 10 ND 2 osuf 10 + -
NA < 10 ND 4 osuf 2 + -
400-800 ND 200-400 2 Simi and 0 
200-400 ND 200-400 2 Simi and 0 
NA ND < 10 2 Simi and 0 + -
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disease and the absence of virus in the post-challenge feces. All 
of the other isolates used failed to protect the piglets against 
both clinical signs of disease and virus shedding. 
The canine and simian rotaviruses which possessed minimal anti-
genic differences by SN, showed cross-protection between them when 
the simian virus was used as the challenge virus and either the 
canine or simian viruses were used as the vaccine. The cell culture 
adapted simian rotavi.rus used for cha 11 enge was not found to be 
virulent to the piglets and thus protection was determined by a lack 
of virus shedding after challenge in the vaccinated animals. 
Virulence of the vaccine virus did not appear to unduly influence 
the immune response. Two out of four of the bovine isolates and the 
canine cell culture adapted rotavirus caused diarrhea with an 
accompanying loss in body weight or a failure to gain weight for two to 
three days in some or all of the piglets. These viruses were judged 
to be virulent. However, despite this severity of infection, none of 
these piglets were protected against challenge with virulent OSU 
rotaviruses. 
It was considered possible that a lack of cross-protection 
between the vaccine .strains and OSU was due to a reduced ability of 
the vaccines isolated from species other than the pig to replicate 
efficiently enough in the intestine of the pig to generate a protective 
immune response. Therefore, vaccine virus shed in the feces was 
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assayed by infectivity in cell culture for a measure of the degree 
of viral multiplication occurring in the gut. The number of immuno-
.fluorescent cells (IC) in cell cultures inoculated with fecal 
supernatants and fixed at 24 hours varied widely among the piglets 
and appeared to correlate with the rotavirus serotype and to the 
number of days after vaccination. A fecal sample, from each of two 
piglets (inoculated with cell culture adapted vaccines) which had 
the highest number of IC at a 6 x 10-l dilution, was selected and 
assayed for infectivity by counting the number of IC. The titers 
(IC per field) of the vaccine cell culture viruses were: bovine, 
18 x 101; OSU, 31 x 103; simian, 21 x 105; and canine, 13 x 104• 
Cell culture adapted bovine rotavirus vaccines were detected only in 
low titers in the feces of .inoculated piglets. However, the piglets 
which developed diarrhea after being inoculated with bovine fecal 
rotavirus vaccines shed virus at titers of approximately 104-105 
IC/field. Based on these results, no correlation was detected 
between the titers of the vaccine virus shed 1 n the feces and pro-
tection against challenge with virulent OSU rotavirus. 
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DISCUSSION 
It is generally accepted that major antigenic differences are 
required to discriminate among different serotypes within a virus 
genus. However, the definition of major antigenic differences is 
not uniform for all viruses. While in this study a 20-fold 
difference in serum neutralization titer was required to differen-
tiate serotypes, much smaller differences are reported as accept.able 
for differentiating other viruses (e.g. influenza A viruses). The 
influenzas, like the rotaviruses, have a segmented genome and are 
well-known for their ability to reassert. As in the rotaviruses, 
problems have been encountered in deciding what degree of antigenic 
difference is required for the recognition of distinct serotypes of 
influenza A viruses. Many isolates have minor antigenic differences 
·as measured by comparative homologous versus heterologous titers of 
antiserum. For this reason, an arbitrary distinction was made 
between serotypes in that only a 4-fold difference in hemagglutination 
titer was considered significant. 30 Although some work in this area 
has been done, 107 this recognition of serotypes remains to be 
confirmed by cross-protection studies. Indeed, according to the 
·world Health Organization, the influenza A viruses are divided into 
subtypes - not serotypes, based upon the antigenic specificity of 
the hemagglutinin and neuraminidase antigens as determined by the 
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double immunodiffusion test. 137 Therefore, based upon the rota-
viruses and influenzas alone, much work remains to be done in the 
area of viral taxonomy concerning the significance or degree of 
importance of antigenic differences. 
The serum neutralization test has been shown to be able to 
detect species-specific antigens of rotaviruses as opposed to the 
group antigens which are demonstrated by complement fixation or 
immunofluorescence. 12 •119 •135 For this reason, the serum neutral-
ization test was selected as the method of choice for differentiating 
rotaviruses in vitro and correlating the in vitro differences with 
in vivo studies on cross-protection. To permit the identification of 
different serotypes with a minimum of cross-reactivity, an arbitrary 
decision was made to accept a difference of no less than 20-fold 
between homologous and heterologous SN titers as being significant. 
As differences of this magnitude were not often observed in 3-4 
week convalescent serum, antisera from hyperimmunized animals (guinea 
pi gs) were used for serotypi ng. 
The greater ability of hyperimmune as compared to convalescent 
antisera to demonstrate antigenic differences among rotaviruses 
confirms work done by others. 34 Interestingly, the guinea pigs used 
for producing hyperimmune antisera had all been previously exposed 
to a rotavirus (or rotaviruses) of unknown origin, as rotavirus-
specific antibody was detected by IF in pre-hyperimmunization sera, 
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although the t1ters were low in most animals. Despite this previous 
exposure, the guinea pigs produced highly specific·antisera. 
In contrast to the hyperimmune antisera, the convalescent 
antisera were more cross-reactive and most were unable to discriminate 
among the rotavirus isolates. However, a dog convalescent to a 
natural infection of a canine rotavirus, and five gnotobiot1c rats 
convalescent to an oral inoculation of canine rotavirus produced 
highly specific antisera. The reasons for these differences in 
specificity among the convalescent antisera are not known. The 
differences in specificity could possibly be due to the antigenic 
structure of the particular rotavirus or to the immune response of the 
animal species used for antiserum production. The heterologous 
titers, reported in Tables l and 4, of sera from pigs convalescent 
to canine rotavirus are different (i.e., those in Table 4 are more 
specific) presumably because the animals were bled at different 
times after inoculation. The animals were bled 3 weeks p.i. for the 
serum neutralization studies (Table 1) and 2 to 3 weeks for the 
cross-protection studies. ·Generally, anti sera from 2 week con val es cent 
animals demonstrated a narrower specificity, whereas specificity 
appeared to have broadened in 3 week convalescent animals. One pig 
which was orally inoculated with OSU rotavirus and also hyperimmunized, 
differentiated among OSU, Bl4, and simian by greater than 20,.fold 
but did not differentiate clearly between OSU and canine rotavirus, 
i.e., less. than 20-fold. 
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The differences between the isolates studied were most easily 
demonstrated by the guinea pig hyperimmune antisera (20-500 fold) and 
as these differences were reflected in a lack of cross-protection 
between each serotype and OSU they therefore are of importance. 
It should be noted that not every guinea pig inoculated produced 
antisera that was clearly able to differentiate among the rota-
viruses. Generally, those producing the lower homologous titers 
were inoculated with rotaviruses which did not multiply to nigh 
titer in cell culture (i.e., Bl4 and WA) whereas those with high 
homologous titers were inoculated with viruses which multiplied to 
high titer in eell culture (i.e., canine rotavirus). Therefore, the 
reason these animals produced less specific antisera may have been 
due to a lower immunizing dose, a failure of an individual animal to. 
mount an efficient immune response or a fault in the immunization 
procedure. 
To conduct the cross-protection studies, an animal model had to 
be selected. The animals investigated to serve as models included 
pigs, calves, and rats. Initial experiments were done using the 
rat to determine if this animal could be used. However, due to the 
expense of the animals, the small amount of fecal material and blood 
that couid be collected, ·and the fact that the canine rotavirus failed 
to cause any detectable clinical signs of disease and could not be 
detected in the feces, the gnotobiotic rats were discontinued in favor 
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of gnotobiotic calves and pigs which were more readily available 
and did not have to be derived elsewhere. Gnotobiotic pigs were 
selected for the cross-protection studies over calves because of 
(a) their comparatively low cost, (b) a number of experiments 
including controls could be done with one litter, and (c) a 
reliably virulent strain of porcine rotavirus (OSU) was available 
for challenge purposes. No such reliably virulent strain was 
available for the calves. 
Several of the isolates studied were found to be virulent to the 
pig. Of these rotaviruses, the porcine strain (OSU) caused the 
most severe disease. It was for this reason that the OSU strain 
was selected as the challenge strain for the cross-protection 
studies. Similar studies done in calves with a virulent bovine rota-
virus showed that cross-protection was less.likely to occur if the 
challenge. virus was virulent as opposed to a challenge virus of low 
or avirulence. 131 •138 Homologous vaccine protection in these studies 
and others64 •126 prevented both clinical disease and virus shedding 
in the feces. _However, heterologous vaccine protection, though 
reported to have prevented clinical signs of disease, did not 
prevent shedding of the challenge virus in the feces. In 1980, 
Tzipori et al •126 reported that piglets vaccinated with human rota-
virus and challenged with porcine rotavirus were protected from clinical 
disease but did become infected and did shed virus in the feces 
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after challenge. It was reported that the animals developed serum 
neutralizing antibody to SA.11 but the response to the porcine or human 
virus was not reported nor were the serological relationships of the 
viruses used. Therefore, it could not be determined if the piglets 
inoculated with the human virus actually developed neutralizing antibody 
to the porcine strain and thus it was not determined if the specificity 
or lack of specificity of the immune response influenced cross-pro-
tection. Another study appearing to point to successful heterologous 
cross-protection was done by Bridger and Brown. 14 They reported that 
bovine colostrum protected piglets from porcine rotavirus challenge. 
However, the colostrum was shown to possess neutralizing antibodies 
against the porcine virus. Another study however seemed to demonstrate 
that milk has poor protective properties in cattle. 110 Wyatt et ai. 138 
also reported heterologous cross-protection when calves vaccinated in 
utero with bovine rotavirus were protected against clinical ·disease when 
challenged with human rotavirus. However, cross-protection did not 
occur with respect to viral shedding in the feces post-challenge. As 
the human virus used in these studies is of low virulence (or even 
avirulence in some studies, G. Woode, Department of Veterinary Micro-, 
biology and Preventive Medi.cine, Iowa State University, personal communi-
cation), it is reasonable to conclude that the calves did not.show full 
cross-protection. Like Tzipori et al, 's study,126 they did not report on 
the immune response of the animals to the challenge virus. In contrast, 
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Woode et a1. 131 reported only a 30% cross-protection rate when foal 
or human virus (provided by Dr. Wyatt) was used to vaccinate calves 
and bovine rotavirus (British isolate) was used as challenge. 
In this study, cross-protection between viruses of the same 
serotype resulted in a lack of clinical signs of disease and a lack 
of virus excretion following challenge. However, this only occurred 
when the homologous vaccine/challenge system was used with OSU 
porcine rotavirus·. The apparent cross-protection between the 
antigenically closely related but not identical viruses, simian 
and canine, may have been a function of the lack of virulence of 
the simian virus used for the challenge. 
Several studies have been published reporting the existence 
of antigenically different rotaviruses (different serotypes) in 
calves, piglets, mice, humans, monkeys, and foals4o,lo5,ll 9,135 
and also 2-3 different serotypes in humans. 118•143 Two viruses 
(canine and simian) in this study belong to the same serotype based 
on serum neutralization and cross-protection. Although this 
observance is unusual,' there have been reports indicating that this 
is not a precedence. These reports suggest natural infections of 
animals or humans with rotaviruses from other species such as, 
children infected with a bovine serotype,18 calves infected with a 
porcine serotype,14 and pigs infected with a bovine serotype (G. 
Woode, personal communication); These reports are based on 
serological evidence. This study shows that the cani.ne and simian 
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rotaviruses belong to the same serotype. Although great care was 
taken in the laboratory to avoid cross-contamination among the 
isolates studied, the possibility that cross-contamination had 
occurred between the simian and canine strains was considered. This 
possibility was soon eliminated. Differences between the two 
isolates could be detected by some of the antisera used, although 
these differences did not meet· the criteria required for the two 
viruses to be placed in different serotypes. One convalescent dog 
sera did discriminate well between them but it is not known if this 
animal was infected with the same strain of canine rotavirus as was 
cultured in the laboratory. The RNA segments of these two isolates 
have been compared by coelectrophoresis. 43 The migration patterns 
differed in at least eight segments (1, 2, 4, 5, 6, 8, 9, 10, and 
possibly 3). These two rotaviruses are very interesting in that 
despite possessing such marked differences in RNA migration patterns 
they are very closely related antigenically and by cross-protection. 
From this data and from previously published studies on other 
rotaviruses, it is predicted that RNA segment 11 codes for the 
major serum neutralizing antigen and segment 2, 3 and 9 code for 
minor and less important neutralizing antigens. 43 It should be 
noted that serotype does not correlate with virulence (e.g., canine was 
judged to be pig virulent, simian was not). Thus, from this limited 
study, the coding for virulence must reside in the RNA segments which 
are different between canine and simian. 
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CONCLUSIONS 
This work and other published studies confirms that there are 
different serotypes of rotavirus as judged by the serum neutralization 
test, that the serum neutralization test has proven to be a reliable 
and easy method for serotyping, and that these different serotypes 
are likely to show poor cross-protective properties. The gnoto-
biotic pig has served well as an animal model for cross-protection 
work because of the number of experiments one litter provides, their 
relatively low cost, and the animals' susceptibility to many 
different strains of rotavirus. From this study, it has also been 
shown that the same serotype of rotavirus can be found naturally in 
different species of animals and that the same serotype can be 
possessed by two very different (as judged by RNA coelectrophoresis) 
viruses. 
In conclusion, since homologous vaccines provide the best 
protection against challenge, rotavirus vaccines should be made 
against all the serotypes to which an animal is likely to be exposed. 
The discovery of two different viruses, canine and simian that possess 
the same serotype raises the possibility of using a virus from one 
animal species as a vaccine for another animal species as long as 
the same serotype exists in both species. It is possible that the 
vaccine virus originating from another species would be of lower 
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virulence for the vaccinated animal. Until studies are done to test 
the feasibility of such an approach or to make viruses through 
genetic reassortment, homologous vaccines appear to be the best 
approach for successful protection. 
l . 
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APPENDIX 
Solutions and Reagents 
Eagles' Minimum Essential Medium (MEM) 
22.0 g NaHC03 
96 .• 06 g Eagles' Minimum Essential Medium powder 
(GIBCO, Grand Island, NY) 
l 0 1 H20 
The solution was prepared, pH adjusted to 6.7 and filter 
sterilized using a 0.45 µm and 0.22 µm filter. The media was stored 
at 4 ° C. 
X-ATV (for cell culture passing) 
8.0 g Trypsin (DIFCO, Detroit, MI) 
32.0 g NaCl 
0.8 g KH2Po4 
4.6 g Na2HP04 
4.0 g EDTA (ethylenediamine tetraacetic acid) (Sigma, St. 
Louis, MO) 
4 1 H20 
The solution was prepared, filter sterilized and stored frozen 
(-24° C) until used. 
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£~ Oxoid Agar (l.2%) 
6.0 g Oxoid agar (Oxoid Ltd., London, England) 
500 ml H20 
The solution was prepared, heat-stabilized and stored at 4° C 
for use. 
Phosphate Buffered.Saline (PBS) 
85.07 g NaCl 
l. 22 g KH 2PO 4 
1.20 g Na2HP04 
10 l H2o 
The solution was prepared and pH adjusted to 7.2. It was heat-
sterilized and stored at 4° C for diluting purposes. For washing 
purposes, PBS was not sterilized and was stored at room temperature. 
Phosphate Buffered Formalin 
59.5 g NaCl 
45.5 g Na2HP04 
28.0 g NaH2Pci4 
6.3 l H20 
0.7 l 37.5% Formaldehyde 
The solution was prepared and stored at room temperature. 
Crystal Violet Stain (1%) 
25 g crystal violet 
500 ml absolute alcohol 
2 l di sti 11 ed water 
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The stain was prepared and stored at room tempe.rature. 
Concentrated'Mineral Supplement for GnOtobiotic Calves·and.Piglets 
49.8 g FeS04 - 7H20 
3.9 g CaS04 - 5H20 
3.6 g MnC1 2 - 4H20 
0.26 g KI 
l l H20 
If a precipitate formed, 2 ml HCl was added. 
Dilutions 
for piglets 
5.3 ml mineral concentrate 
l l H20 
for calves 
3.53 ml mineral concentrate 
The supplement was heat-sterilized. 
